GSK Prescribes A US$3.5bn Bond In Three Parts
March 19, 2019 at 16:06 PM EDT
British pharma GlaxoSmithKline joined the recent groundswell of high-grade corporate bond issuers Monday to sell new debt.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|